Literature DB >> 12588893

Regulation of Stat3 nuclear export.

Samita Bhattacharya1, Christian Schindler.   

Abstract

Stat3 is the most pleiotropic member of the signal transducer and activator of transcription (STAT) family of transcription factors and mediates pivotal responses for the cytokine family. In resting cells, STATs, including Stat3, reside largely in the cytoplasm. Upon cytokine stimulation, they rapidly translocate to the nucleus, where they promote the expression of target genes. During the subsequent period of signal decay they are re-exported back to the cytoplasm in preparation for the next round of signaling. This process of nuclear export can be blocked by the fungal toxin leptomycin B (LMB). In contrast to what appears to be the case for Stat1, LMB treatment not only blocks the poststimulation export of Stat3 from the nucleus back to the cytoplasm, but also promotes the nuclear accumulation of Stat3 in resting cells. Remarkably, the LMB-dependent nuclear accumulation of Stat3 in resting cells is independent of tyrosine phosphorylation, highlighting the existence of a "basal" signaling pathway. Subsequent studies identified three nuclear export signal (NES) elements. Two of these elements, Stat3(306-318) and Stat3(404-414), corresponded to those recently identified in Stat1, and a third, Stat3(524-535), is novel. Stat3(306-318) appears to be important in the rapid nuclear export seen after stimulation (poststimulation export), whereas the Stat3(404-414) and Stat3(524-535) play a more important role in regulating basal nuclear export. In summary, these studies indicate that the process of Stat3 nuclear export is dependent on multiple NES elements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588893      PMCID: PMC151917          DOI: 10.1172/JCI15372

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

Authors:  B R Henderson; A Eleftheriou
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

Review 2.  The Stat family in cytokine signaling.

Authors:  J N Ihle
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor.

Authors:  K M McBride; C McDonald; N C Reich
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

4.  Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain.

Authors:  A Begitt; T Meyer; M van Rossum; U Vinkemeier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

5.  A Stat3-interacting protein (StIP1) regulates cytokine signal transduction.

Authors:  R G Collum; S Brutsaert; G Lee; C Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.

Authors:  C L Yu; Y J Jin; S J Burakoff
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

Review 7.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

8.  Regulation of STAT1 nuclear export by Jak1.

Authors:  K Mowen; M David
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  Tyrosine phosphorylation-independent nuclear translocation of a dictyostelium STAT in response to DIF signaling.

Authors:  M Fukuzawa; T Araki; I Adrian; J G Williams
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

10.  Murine Stat2 is uncharacteristically divergent.

Authors:  C Park; M J Lecomte; C Schindler
Journal:  Nucleic Acids Res       Date:  1999-11-01       Impact factor: 16.971

View more
  46 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.

Authors:  Kellie R Machlus; Stephen K Wu; Prakrith Vijey; Thomas S Soussou; Zhi-Jian Liu; Eran Shacham; T J Unger; Trinayan Kashyap; Boris Klebanov; Martha Sola-Visner; Marsha Crochiere; Joseph E Italiano; Yosef Landesman
Journal:  Blood       Date:  2017-06-19       Impact factor: 22.113

Review 3.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy.

Authors:  Paul M Tyler; Mariah M Servos; Romy C de Vries; Boris Klebanov; Trinayan Kashyap; Sharon Sacham; Yosef Landesman; Michael Dougan; Stephanie K Dougan
Journal:  Mol Cancer Ther       Date:  2017-02-01       Impact factor: 6.261

Review 5.  Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system.

Authors:  Shella Saint Fleur; Hodaka Fujii
Journal:  Cytokine       Date:  2008-01-18       Impact factor: 3.861

6.  Effect of CLIP3 Upregulation on Astrocyte Proliferation and Subsequent Glial Scar Formation in the Rat Spinal Cord via STAT3 Pathway After Injury.

Authors:  Xiaoqing Chen; Cheng Chen; Jie Hao; Jiyun Zhang; Feng Zhang
Journal:  J Mol Neurosci       Date:  2017-12-07       Impact factor: 3.444

7.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Authors:  Antje K Kretzschmar; Michaela C Dinger; Christian Henze; Katja Brocke-Heidrich; Friedemann Horn
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

9.  Crif1 is a novel transcriptional coactivator of STAT3.

Authors:  Min-chul Kwon; Bon-Kyoung Koo; Jin-Sook Moon; Yoon-Young Kim; Ki Cheol Park; Nam-Shik Kim; Mi Yi Kwon; Myung-Phil Kong; Ki-Jun Yoon; Sun-Kyoung Im; Jaewang Ghim; Yong-Mahn Han; Sung Key Jang; Minho Shong; Young-Yun Kong
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

10.  Model-based extension of high-throughput to high-content data.

Authors:  Andrea C Pfeifer; Daniel Kaschek; Julie Bachmann; Ursula Klingmüller; Jens Timmer
Journal:  BMC Syst Biol       Date:  2010-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.